Trial Details

COMPLETED
Basic Information
Clinical ID c4360
Identifier NCT00626288
Trial Title Mesalazine Therapy in Patients With Irritable Bowel Syndrome
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Irritable Bowel Syndrome
Interventions DRUG: Mesalazine|DRUG: Placebo
Participant Information
Sponsor SOFAR S.p.A.
City Ancona
Country/Region Italy
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2007-12
Primary Completion Date 2012-03
Completion Date 2012-07